CompanyTrack
I

IMMUNOBIOLOGY LIMITED

Active Cambridge

Research and experimental development on biotechnology

3 employees Website
Life sciences and medical technology Research and experimental development on biotechnology
I

IMMUNOBIOLOGY LIMITED

Research and experimental development on biotechnology

Founded 26 May 1999 Active Cambridge, United Kingdom 3 employees immbio.net
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 30 May 2025
Confirmation Statement Submitted 28 Feb 2025
Net assets £-171.66K £39.23K 2024 year on year
Total assets £0.00 £53.84K 2024 year on year
Total Liabilities £96.93K £89.35K 2024 year on year
Charges None No charges registered

AI Analysis

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Registered Address

Babraham Research Campus Babraham Cambridge CB22 3AT

Office ()

Cambridge, Cambridgeshire, United Kingdom, Europe

Website

immbio.net

Credit Report

Discover IMMUNOBIOLOGY LIMITED's Credit Score, limit, and payment likelihood.

Mutual Companies

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2014–2024)

Cash in Bank

N/A

Decreased by £52.10k (-100%)

Net Assets

-£171.66k

Decreased by £39.23k (-30%)

Total Liabilities

£96.93k

Decreased by £89.35k (-48%)

Turnover

N/A

Employees

3

Debt Ratio

N/A

Decreased by 346 (-100%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

£5.5m raised
Show:

Investors (3)

Investor NameInvestor SinceParticipating Rounds
European UnionFeb 2020Unattributed
Chord CapitalFeb 2020Unattributed
InventagesFeb 2020Unattributed

Share Capital

Share Capital

Share allotments and capital structure

11 Allotments 170,200,120 Shares £29429460.29m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
13 May 202513,999,999£2.10m£0.15
13 May 202513,999,999£2.10m£0.15
7 Feb 20207,500,000£150k£0.02
12 Mar 201920,100,000£201k£0.01
29 May 201866,000,000£330k£0.005

Officers

Officers

3 active 18 resigned
Status
David Allan BellDirectorBritishEngland5416 Aug 2012Active
Graham John ClarkeDirectorBritishEngland6922 Jan 2001Active
William Thomas MasonDirectorAmericanUnited Kingdom743 Apr 2019Active

Shareholders

Shareholders (53)

Wood/buxton Trust 2
0.7%
1,500,00028 Feb 2025
Wood/buxton Trust 2
0.2%
500,00028 Feb 2025
Wood/buxton Trust 2
0.1%
254,74528 Feb 2025

Persons with Significant Control

Persons with Significant Control (2)

2 Active 1 Ceased

Mark Robert Blandford

British

Active
Notified 12 Mar 2019
Residence United Kingdom
DOB November 1957
Nature of Control
  • Ownership Of Shares 25 To 50 Percent

British Smaller Technology Companies Vct 2 Plc

United Kingdom

Active
Notified 6 Apr 2016
Nature of Control
  • Ownership Of Shares 25 To 50 Percent

Rockridge Investments, S.a

Ceased 6 Apr 2016

Ceased

Group Structure

Group Structure

IMMUNOBIOLOGY LIMITED Current Company

Charges

Charges

No charges registered

Documents

Company Filings

DateCategoryDescriptionDocument
11 Jun 2025CapitalAllotment of shares (GBP 3,076,534.657) on 2025-05-13View(5 pages)
31 May 2025GazetteGazette Filings Brought Up To DateView(1 page)
30 May 2025AccountsAnnual accounts made up to 2024-05-31View(3 pages)
27 May 2025CapitalAllotment of shares (GBP 3,076,534.657) on 2025-05-13View(5 pages)
16 May 2025DissolutionDissolved Compulsory Strike Off SuspendedView(1 page)
11 Jun 2025 Capital

Allotment of shares (GBP 3,076,534.657) on 2025-05-13

31 May 2025 Gazette

Gazette Filings Brought Up To Date

30 May 2025 Accounts

Annual accounts made up to 2024-05-31

27 May 2025 Capital

Allotment of shares (GBP 3,076,534.657) on 2025-05-13

16 May 2025 Dissolution

Dissolved Compulsory Strike Off Suspended

Recent Activity

Latest Activity

Allotment of shares (GBP 3,076,534.657) on 2025-05-13

8 months ago on 11 Jun 2025

Gazette Filings Brought Up To Date

8 months ago on 31 May 2025

Annual accounts made up to 2024-05-31

8 months ago on 30 May 2025

Allotment of shares (GBP 3,076,534.657) on 2025-05-13

8 months ago on 27 May 2025

Dissolved Compulsory Strike Off Suspended

9 months ago on 16 May 2025